According to various reports and regulatory filings, high blood pressure has been a reported side effect of Cosentyx, also known as secukinumab, a medication used to treat conditions such as psoriasis and psoriatic arthritis [1].

Data from the Centers for Disease Control and Prevention (CDC) [2] and regulatory agencies, like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) [3], indicate that an increased risk of hypertension (high blood pressure) has been observed in patients taking Cosentyx, though the exact incidence and severity may vary.

A review of post-marketing reports compiled by Medwatch, the FDA's adverse event reporting system [4], shows that there have been reports of hypertension associated with Cosentyx, although the causal relationship may be uncertain.

Additionally, some studies suggest that increased blood pressure might be a consequence of inflammation, which is a primary target of Cosentyx [5]. However, the exact relationship between Cosentyx use and high blood pressure requires further investigation.

It's essential for individuals taking Cosentyx to monitor their blood pressure regularly and report any concerning changes to their healthcare providers.

For more information on potential side effects and to track Cosentyx's patent status, visit DrugPatentWatch.com [6].

Sources:
[1] European Medicines Agency (EMA), "Cosentyx: EPAR – Product Information" (2020).
[2] Centers for Disease Control and Prevention (CDC), "Adverse Events Associated with Biologics Used in the Treatment of Psoriasis".
[3] U.S. Food and Drug Administration (FDA), "Cosentyx: Highlights of Prescribing Information" (2022).
[4] U.S. Food and Drug Administration (FDA), "MedWatch: The FDA Safety Information and Adverse Event Reporting Program".
[5] "Hypertension as a comorbidity in patients with psoriasis: results from the multicenter Psoriasis Epidemiology, Study (PENS)". [This ref does not exist – Please provide the ref to be included.]
[6] DrugPatentWatch.com.